Galantamine Improves Cognition in Schizophrenic Patients Stabilized on Risperidone
- 15 September 2006
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 60 (6) , 530-533
- https://doi.org/10.1016/j.biopsych.2006.04.006
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicityBiochemical and Biophysical Research Communications, 2004
- The principal features and mechanisms of dopamine modulation in the prefrontal cortexProgress in Neurobiology, 2004
- Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine ReleaseMolecular Pharmacology, 2004
- Genes and the parsing of cognitive processesTrends in Cognitive Sciences, 2004
- Galantamine for Treatment-Resistant SchizophreniaAmerican Journal of Psychiatry, 2002
- Relationship of the Use of Adjunctive Pharmacological Agents to Symptoms and Level of Function in SchizophreniaAmerican Journal of Psychiatry, 2002
- Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trialJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic TreatmentAmerican Journal of Psychiatry, 2001
- The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical ValidityJournal of Clinical and Experimental Neuropsychology, 1998
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970